aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Avalon GloboCare, founded with a mission to revolutionize biotechnology and healthcare services, focuses on developing diagnostic and therapeutic products. The company specializes in stem cell banking, oral cancer detection, and skin regeneration. Additionally, Avalon GloboCare has expanded its product line to include the KetoAir Breathalyzer, which monitors ketosis levels. Their market focus spans globally, serving clients worldwide with innovative healthcare solutions.
Notable figures affiliated with Avalon GloboCare include key investors and industry experts who have propelled the company's growth. The firm has achieved significant milestones, such as launching the KetoAir Breathalyzer in the U.S. and securing an exclusivity agreement for its distribution across multiple regions. Avalon GloboCare's impact is evident in its contributions to advancing medical diagnostics and therapeutic technologies, positioning itself as a leader in the biotech industry.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Stem Cell Banking
Technology
Biotech
Tags
Biotech
Model Types
Professional Services
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was Avalon GloboCare founded?
Avalon GloboCare was founded in 2014.
Where is Avalon GloboCare's headquarters located?
Avalon GloboCare's headquarters is located in Freehold, NJ, US.
When was Avalon GloboCare's last funding round?
Avalon GloboCare's most recent funding round was for $20M (USD) in September 2019.
How many employees does Avalon GloboCare have?
Avalon GloboCare has 5 employees as of Feb 5, 2024.
How much has Avalon GloboCare raised to-date?
As of July 05, 2023, Avalon GloboCare has raised a total of $25.1M (USD) since Sep 3, 2019.
Add Comparison
Total Raised to Date
$25.1M
USD
Last Update Sep 3, 2019
Last Deal Details
$20M
USD
Sep 3, 2019
Post Ipo Equity
Total Employees Over Time
5
As of Feb 2024
Avalon GloboCare Address
4400 Route 9 South
Suite 3100
Freehold,
New Jersey
07728
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts